Echovirus Infections: Clinical Trials

2 trials for Echovirus Infections, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Not yet recruiting 1

Follow Echovirus Infections: new trials by email Literature Review of Echovirus Infections trials Research Report on Echovirus Infections

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), Placebo - Hand, Foot, and Mouth Disease(HFMD), Herpangina
Phase 3Not yet recruitingSinovac Biotech Co., Ltd60002026-05-012026-05-28
A Clinical Trial to Assess the Efficacy and Safety of an Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children Aged 6-35 Months
inactivated vaccine (Vero Cell) against EV71, 0/0.5ml placebo - Hand, Foot and Mouth Disease, Herpangina
Phase 3CompletedJiangsu Province Centers for Disease Control and Prevention102452012-01-012013-03-29

Narrower conditions

Hand, Foot and Mouth Disease (2)  ·  Herpangina (2)

Broader conditions

Coxsackievirus Infections (2)  ·  Enterovirus Infections (2)  ·  Infections (2)  ·  Picornaviridae Infections (2)  ·  RNA Virus Infections (2)  ·  Virus Diseases (2)

Interventions

Vaccines, Inactivated (1)

Sponsors

Jiangsu Province Centers for Disease Control and Prevention (1)  ·  Sinovac Biotech Co., Ltd (1)

Countries

China (2)

Top investigators

Feng-Cai Zhu, Master (1)  ·  Yanxia Wang (1)

Results publications

PMID 23726161, PMID 28077584, PMID 28548626